Racial difference in the relationship of an angiotensin I-converting enzyme gene polymorphism to serum angiotensin I-converting enzyme activity

Hypertension
L J BloemJ H Pratt

Abstract

An insertion (I)/deletion (D) polymorphism of the angiotensin I-converting enzyme (ACE) gene that has been associated with certain cardiovascular disorders accounts for nearly half the variation in serum ACE level in white subjects. Whether a similar association of serum ACE with the I/D polymorphism occurs in other racial groups is not known. We studied the I/D polymorphism of ACE in relation to serum ACE activity in 141 white and 62 black healthy, unrelated children and adolescents (mean age, 14.7 years). The mean level of ACE activity in whites homozygous for the D allele was higher than in heterozygotes (P = .002) and in homozygotes for the I allele (P = .0001), consistent with an earlier study. In blacks, on the other hand, no significant difference in serum ACE activity between genotypes was observed. An additional finding was a significantly positive relationship between serum ACE activity and diastolic pressure (P = .009). In children and adolescents, serum ACE activity is related to the ACE gene I/D polymorphism in whites but not in blacks. The results indicate a potentially important ethnic variation in genetic regulation of serum ACE activity and the relationship of the I/D polymorphism to cardiovascular disease.

Associated Clinical Trials

References

Jun 1, 1976·Annals of Internal Medicine·N M KaplanC Gomez-Sanchez
Jan 1, 1976·Annals of the New York Academy of Sciences·P E Sartwell
Apr 15, 1992·Biochemical and Biophysical Research Communications·R Y ZeeB J Morris
Jan 1, 1991·The International Journal of Biochemistry·N M Hooper
Oct 26, 1989·The New England Journal of Medicine·J H PrattN S Fineberg
Jul 1, 1986·The Journal of Clinical Investigation·D J Campbell, J F Habener
Mar 2, 1972·The New England Journal of Medicine·H R BrunnerF R Bühler
Aug 22, 1969·Science·T E Reed
Apr 1, 1982·The Journal of Clinical Endocrinology and Metabolism·T A KotchenJ M Kotchen
Mar 16, 1995·The New England Journal of Medicine·K LindpaintnerC H Hennekens
Sep 1, 1994·The Journal of Clinical Investigation·B J MorrisA P Schrader
Jan 1, 1994·Nature Genetics·F SchächterD Cohen
Jul 1, 1993·Hypertension·A K ManatungaJ H Pratt
Jan 29, 1993·Science·L L Cavalli-SforzaA Piazza

❮ Previous
Next ❯

Citations

Mar 22, 2002·Analytical Biochemistry·Theodore E CureyJason B Shear
Jul 5, 2001·Biochemical and Biophysical Research Communications·H TakatsuT Adachi
Jan 31, 2007·Naunyn-Schmiedeberg's Archives of Pharmacology·Dieter RosskopfRafael Schäfers
Dec 18, 2012·Current Hypertension Reports·Patricia C Underwood, Gail K Adler
May 15, 1989·Clinica Chimica Acta; International Journal of Clinical Chemistry·T YamamotoO Takatori
Jun 1, 1994·Clinica Chimica Acta; International Journal of Clinical Chemistry·E SchnaithW Rick
May 7, 2011·Transactions of the Royal Society of Tropical Medicine and Hygiene·Hala M RaslanHassan E El-Batae
May 15, 2002·The American Journal of Cardiology·Yuji MizunoKazuwa Nakao
May 4, 2001·The American Journal of Medicine·E J Eichhorn
Apr 3, 1998·Journal of the American College of Cardiology·J L AndersonR H Ward
Feb 13, 2001·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·H YoshiiT Itani
Jan 5, 2006·European Journal of Human Genetics : EJHG·Colin N MoranYannis P Pitsiladis
Mar 11, 2004·La Revue du praticien·Eric Alamartine
Nov 23, 2000·The New England Journal of Medicine·C J Young, R S Gaston
Jun 2, 2001·The New England Journal of Medicine·UNKNOWN Beta-Blocker Evaluation of Survival Trial InvestigatorsPhilip W Lavori
Dec 3, 2002·Diabetes Technology & Therapeutics·David W Moskowitz
Jun 22, 2000·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·M C HsiehJ H Tsai
Nov 11, 1999·Current Opinion in Lipidology·J P O'MalleyD R Illingworth
Apr 26, 2003·Heart Disease·Benjamin M SchaeferPamela Charney
Nov 10, 2009·Pharmacogenetics and Genomics·Caroline F ThornRuss B Altman
Jan 18, 2007·Annals of Human Genetics·J R PayneH E Montgomery
Nov 9, 2004·International Journal of Clinical Practice·H V GunesG Kudaiberdieva
Nov 17, 1998·American Journal of Respiratory and Critical Care Medicine·M J MaliarikM C Iannuzzi
Jul 21, 2001·American Journal of Respiratory and Critical Care Medicine·D S McGrathV Dolek
Mar 18, 2009·Cardiovascular Diabetology·Joey C EisenmannKate A Heelan
Nov 7, 2002·Circulation Journal : Official Journal of the Japanese Circulation Society·Chin-Hsiao Tseng, Ching-Ping Tseng
Mar 21, 2001·Pharmacogenomics·R Butler
Jul 14, 1999·Journal of Hypertension·A V FerreiraR S Cunha
Jun 9, 2005·Journal of Hypertension·Philip B Mellen, David M Herrington

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.